| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 2543 |
| 1 | RIVAROXABAN | 1155 |
| 2 | ASPIRIN | 879 |
| 3 | ASPIRIN 325 MG | 830 |
| 4 | ASPIRIN 81 MG | 830 |
| 5 | APIXABAN | 639 |
| 6 | ADALIMUMAB | 551 |
| 7 | CLOPIDOGREL | 525 |
| 8 | FUROSEMIDE | 454 |
| 9 | METOPROLOL TARTRATE | 378 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FACTOR XIII CONCENTRATE (HUMAN) | 5 | 0.0549 |
| 1 | THROMBIN HUMAN AND FIBRINOGEN | 11 | 0.0327 |
| 2 | ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX (HUMAN) | 30 | 0.0274 |
| 3 | PROTAMINE SULFATE | 44 | 0.0239 |
| 4 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL | 33 | 0.0199 |
| 5 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 20 | 0.0179 |
| 6 | COAGULATION FACTOR IX (RECOMBINANT), FC FUSION PROTEIN | 44 | 0.0178 |
| 7 | BIVALIRUDIN | 17 | 0.0171 |
| 8 | VON WILLEBRAND FACTOR (RECOMBINANT) | 5 | 0.0159 |
| 9 | FONDAPARINUX SODIUM | 106 | 0.0131 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 2559 |
| 1 | Progestin-containing Intrauterine System [EPC] | 2543 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1411 |
| 3 | Factor Xa Inhibitor [EPC] | 1309 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 905 |
| 5 | Corticosteroid [EPC] | 693 |
| 6 | Loop Diuretic [EPC] | 515 |
| 7 | Kinase Inhibitor [EPC] | 419 |
| 8 | Proton Pump Inhibitor [EPC] | 399 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 389 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue Factor Pathway Inhibitor Antagonist [EPC] | 1 | 0.0222 |
| 1 | Human Blood Coagulation Factor [EPC] | 11 | 0.0134 |
| 2 | Humanized Monoclonal Antibody Fragment [EPC] | 18 | 0.0126 |
| 3 | Progestin [EPC] | 2559 | 0.0088 |
| 4 | Anti-coagulant [EPC] | 24 | 0.0064 |
| 5 | Antifibrinolytic Agent [EPC] | 55 | 0.0056 |
| 6 | Factor Xa Inhibitor [EPC] | 1309 | 0.0048 |
| 7 | Copper-containing Intrauterine Device [EPC] | 229 | 0.0046 |
| 8 | Serotonin-4 Receptor Agonist [EPC] | 3 | 0.0046 |
| 9 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |